Book chapter
CFTR‐Associated Pancreatic Disease
The Pancreas, pp.390-395
John Wiley & Sons, Ltd, Fourth edition
08/07/2023
DOI: 10.1002/9781119876007.ch47
Abstract
Cystic fibrosis transmembrane conductance regulator ( CFTR ) is critical for pancreas health. Its deficiency leads to a variety of pancreatic damage from recurrent inflammation to chronic damage, exocrine pancreatic insufficiency, diabetes, and potentially cancer. Emerging therapies suggest that correcting and/or modulating CFTR function in the pancreas may prevent recurrent attacks of pancreatitis in people with cystic fibrosis and potentially delay or reverse ongoing pancreatic destruction.
Details
- Title: Subtitle
- CFTR‐Associated Pancreatic Disease
- Creators
- Chee Y OoiAliye Uc
- Contributors
- Hans G Beger (Editor)Markus W Büchler (Editor)Ralph H Hruban (Editor)Julia Mayerle (Editor)John P Neoptolemos (Editor)Tooru Shimosegawa (Editor)Andrew L Warshaw (Editor)David C Whitcomb (Editor)Yupei Zhao (Editor)Christiane Groß (Editor)
- Resource Type
- Book chapter
- Publication Details
- The Pancreas, pp.390-395
- Edition
- Fourth edition
- DOI
- 10.1002/9781119876007.ch47
- Publisher
- John Wiley & Sons, Ltd; Chichester, UK
- Number of pages
- 6
- Language
- English
- Date published
- 08/07/2023
- Academic Unit
- Stead Family Department of Pediatrics; Radiation Oncology; Gastroenterology, Hepatology, Pancreatology, and Nutrition
- Record Identifier
- 9984448059802771
Metrics
22 Record Views